Inovio Pharmaceuticals In... (INO)
NASDAQ: INO
· Real-Time Price · USD
2.43
-0.03 (-1.22%)
At close: Oct 03, 2025, 3:59 PM
2.45
0.82%
After-hours: Oct 03, 2025, 07:19 PM EDT
-1.22% (1D)
| Bid | 2.08 |
| Market Cap | 129.14M |
| Revenue (ttm) | 182.34K |
| Net Income (ttm) | -44.9B |
| EPS (ttm) | -2.59 |
| PE Ratio (ttm) | -0.94 |
| Forward PE | -1.63 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 2.74 |
| Volume | 741,313 |
| Avg. Volume (20D) | 1,977,553 |
| Open | 2.48 |
| Previous Close | 2.46 |
| Day's Range | 2.38 - 2.54 |
| 52-Week Range | 1.30 - 5.83 |
| Beta | 1.66 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for INO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsInovio Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 13, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-37.85%
Inovio Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
3 months ago
+4.9%
Inovio shares are trading lower after the company announced a proposed public offering.
1 month ago · seekingalpha.com
Inovio Pharmaceuticals, Inc. (INO) Q2 2025 Earnings Call TranscriptInovio Pharmaceuticals, Inc. (NASDAQ:INO ) Q2 2025 Earnings Conference Call August 12, 2025 4:30 PM ET Company Participants Jacqueline E. Shea - CEO, President & Director Jennie Willson - Corporate Pa...
